Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study

Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study

Abstract Objective Coronavirus disease 2019 (COVID-19) is a major challenge facing the world. Certain guidelines issued by National Health Commission of the People's Repubilic of China recommend intravenous immunoglobulin (IVIG) for adjuvant treatment of COVID-19. However, there is a lack of cl...

Full description

Bibliographic Details
Main Authors: Xiao Hou, Li Tian, Lei Zhou, Xinhua Jia, Li Kong, Yitao Xue, Hao Hao, Xianqing Meng, Feihu Zhang, Xiaobin Dong
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Virology Journal
Subjects:
SARS-CoV-2
COVID-19
IVIG
Mortality
Mechanical ventilation
Hospital length of stay
Online Access:https://doi.org/10.1186/s12985-021-01575-3

Internet

https://doi.org/10.1186/s12985-021-01575-3

Similar Items